Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06529341
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-06
Brief Title:
Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 Current research has found that tDCS has a positive effect on improving the negative attention bias of AD patients and this study uses HD-tDCS intervention to improve the cognitive function and neural mechanisms of AD patients in the OFC to provide a theoretical basis for AD neural mechanism research Verify Hypothesis 1 HD-tDCS cathodal stimulation of the left OFC reduces the excitability of this region modulates its connectivity with the attentional function network and thus changes the emotional experience of social threat
2 Currently there is no consensus on the stimulation parameters for tDCS in the treatment of AD and more evidence is needed to prove and explore It is hoped that the HD-tDCS intervention protocol will become an effective treatment method for improving cognitive function and clinical symptoms in AD patients Hypothesis 2 The HD-tDCS with intensified stimulation parameters 2mA twice a day with a 20-minute interval for 5 consecutive days has an impact on the main and secondary clinical variables of AD patients
2 Currently there is no consensus on the stimulation parameters for tDCS in the treatment of AD and more evidence is needed to prove and explore It is hoped that the HD-tDCS intervention protocol will become an effective treatment method for improving cognitive function and clinical symptoms in AD patients Hypothesis 2 The HD-tDCS with intensified stimulation parameters 2mA twice a day with a 20-minute interval for 5 consecutive days has an impact on the main and secondary clinical variables of AD patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None